MEDISAN released its performance for the first half of the year, turning from profit to a loss of 92.3904 million yuan
According to the Zhitong Finance APP, MEDISAN released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 413 million yuan, a year-on-year decrease of 21.08%. The net loss attributable to shareholders of the listed company was 92.3904 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 89.1959 million yuan. The basic loss per share was 0.29 yuan
According to the Zhitong Finance APP, MEDISAN (002900.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 413 million yuan, a year-on-year decrease of 21.08%. The net loss attributable to shareholders of the listed company was 92.3904 million yuan. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 89.1959 million yuan. The basic loss per share was 0.29 yuan
